Pharmafile Logo
Pharmafocus logo
Advanced Search

Pfizer

Showing 15 posts of 894 posts found.

512px-ugur_sahin_01

BioNTech Chief says COVID-19 vaccine could mean “normal winter” next year

November 16, 2020
Research and Development, Sales and Marketing BioNTech, COVID-19, Pfizer, Vaccine

The advent of an effective vaccine could mean a return to normalcy by next winter, argues Professor Uğur Şahin, Professor …

News
shutterstock_2

Israel to reserve 8m doses of Pfizer/BioNTech’s COVID-19 vaccine

November 13, 2020
Manufacturing and Production, Medical Communications BioNTech, COVID-19, Pfizer, Vaccine, israel

Israeli Health Minister Yuli Edelstein has confirmed the nation’s plans to strike an agreement with Pfizer to secure eight million …

News
steven_ferdman-getty_images

Pfizer CEO cashes in shares for $5.6m following strong Phase 3 COVID-19 vaccine data

November 12, 2020
Sales and Marketing COVID-19, Pfizer, Vaccine, pharma

With the news that Pfizer and BioNTech’s COVID-19 vaccine candidate demonstrated 90% efficacy in a Phase 3 interim analysis, it …

News
vaccination-1215279_960_720

Pfizer and BioNTech’s COVID-19 vaccine shows 90% efficacy in interim analysis

November 10, 2020
Manufacturing and Production, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have ignited a wave of hope with the announcement of positive Phase 3 data demonstrating that their …

News

Pfizer won’t apply for COVID-19 vaccine emergency authorisation until after US election, CEO says

October 19, 2020
Sales and Marketing COVID-19, Pfizer, US, Vaccine

The Chief Executive Officer of Pfizer has said that the company will now submit their vaccine for FDA Emergency Use …

News
bavencio

Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma

October 13, 2020
Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC

The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizer’s combination of their PD-L1 inhibitor immunotherapy …

News
injection-2248377_960_720

EMA launches rolling regulatory review of Pfizer and BioNTech’s COVID-19 vaccine

October 7, 2020
Research and Development, Sales and Marketing BioNTech, COVID-19, EMA, Pfizer, Vaccine

European Medicines Agency has launched a “rolling review” of the promising COVID-19 vaccine candidate BNT162b2 currently in development from BioNTech …

News
800px-pfizer_finland_hq_february_13_2009

Pfizer’s coronavirus vaccine shows moderate side-effects in clinical study

September 16, 2020
Research and Development COVID-19, Pfizer, Pfizer vaccine, coronavirus vaccine

Pfizer has said that participants in a late-stage trial for its COVID-19 vaccine candidate have shown mild to moderate side …

News
800px-pfizer_finland_hq_february_13_2009

Pfizer CEO says company’s COVID-19 vaccine will be available this year if FDA approves the candidate by October

September 14, 2020
Sales and Marketing Pfizer, Pfizer vaccine, Vaccine

Albert Bourla, the CEO of Pfizer, has said that the company’s vaccine for COVID-19 could be used by the general …

News
img_4190-e1376666350337-web

MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme

September 3, 2020
Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma

It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …

News
450px-official_portrait_of_owen_smith_crop_2_1

Former MP and Labour leadership candidate joins Bristol Myers Squibb

August 20, 2020
Business Services Big Pharma, Pfizer

Owen Smith, the former Labour MP and leadership candidate, has joined Bristol Myers Squibb as its UK Government Relations Director. Smith …

News
nice_reception

Bavencio+Inylta combo approved or Cancer Drugs Fund in advanced renal cell carcinoma

July 31, 2020
Medical Communications, Sales and Marketing Merck, NICE, Pfizer, pharma

NICE has revealed that a combination of Merck KGaA’s Bavencio (avelumab) and Pfizer’s Inlyta (axitinib) will be made available as …

News
800px-smallpox_vaccine

Pfizer and BioNTech’s COVID-19 vaccine shows promise in another early stage study

July 22, 2020
Research and Development BioNTech, COVID-19, Pfizer, Vaccine, pharma

BioNTech and Pfizer have revealed more promising early data on their lipid nanoparticle formulated, nucleoside-modified messenger RNA vaccine candidate against …

News
vaccination-1215279_960_720

Promising early immunogenicity data for Pfizer and BioNTech’s COVID vaccine candidate

July 3, 2020
Medical Communications, Research and Development BioNTech, COVID-19, Pfizer, Vaccine

Pfizer and BioNTech have revealed new efficacy findings on the “most advanced” of four candidates being worked on as part …

News
Pfizer headquarters

Pfizer sues US for permission to help Medicare patients with rare heart conditions

June 29, 2020
Sales and Marketing Medicaid, Medicare, Pfizer

Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026